首页|期刊导航|中华医学杂志（英文版）|Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion

Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion

Cun-Liang Cai Ming-Qiang Zhang Jun Guo Li-Wan Wang Jing-Quan Zhao Wen-Jia Guo Xiang-Dong Mu

中华医学杂志（英文版）2019，Vol.132Issue(24)：3003-3005,3.

中华医学杂志（英文版）2019，Vol.132Issue(24)：3003-3005,3.DOI:10.1097/CM9.0000000000000556

Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion

Cun-Liang Cai ¹Ming-Qiang Zhang ¹Jun Guo ¹Li-Wan Wang ¹Jing-Quan Zhao ¹Wen-Jia Guo ¹Xiang-Dong Mu¹

作者信息

1. Department of Respiratory and Critical Care Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China
折叠

摘要

引用本文复制引用

Cun-Liang Cai,Ming-Qiang Zhang,Jun Guo,Li-Wan Wang,Jing-Quan Zhao,Wen-Jia Guo,Xiang-Dong Mu..Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion[J].中华医学杂志（英文版）,2019,132(24):3003-3005,3.

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINESCI

ISSN：0366-6999

访问量0

下载量0

段落导航